Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB.

The dietary antioxidant Curcumin has been proposed for cancer chemoprevention since it induces apoptosis and inhibits the formation of breast cancer metastases. Curcumin acts through the inhibition of phosphorylation of the inhibitor of kappa B (IkappaB), which in turn reduces the nuclear translocation of nuclear factor kappa B (NFkappaB), an inflammation- and cell survival-related transcription factor. However, it is not clear whether the strong antimetastatic effect can exclusively be explained by inhibition of NFkappaB. Here, we addressed the effects of Curcumin (IC(50) = 17 muM) in MDA-MB-231 breast cancer cells using microarray gene expression analyses. Among the 62 genes whose expression was significantly altered, we found the two inflammatory cytokines CXCL1 and -2 (Groalpha and -beta) that were downregulated. Further validation of the microarray results by quantitative real-time reverse transcription-polymerase chain reaction, western blots and enzyme-linked immunosorbent assay revealed that Curcumin impairs transcription of CXCL1 and -2 >24 h and reduces the corresponding proteins. Using small interfering RNA techniques, we elucidated the underlying molecular mechanism revealing that reduction of CXCL1 and -2 messenger RNA levels is NFkappaB dependent and requires intact IkappaBalpha expression. Moreover, CXCL1 and -2 silencing leads to downregulation of several metastasis-promoting genes among which we found the cytokine receptor CXCR4. We therefore suggest that the decrease of CXCL1 and -2 mediated by Curcumin is involved in the inhibition of metastasis.

[1]  A. Gescher,et al.  Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine , 2007, Cancer Chemotherapy and Pharmacology.

[2]  E. Schleicher,et al.  The Chemopreventive Polyphenol Curcumin Prevents Hematogenous Breast Cancer Metastases in Immunodeficient Mice , 2006, Cellular Physiology and Biochemistry.

[3]  Anuj Sharma,et al.  Multiple molecular targets in cancer chemoprevention by curcumin , 2006, The AAPS Journal.

[4]  M. O'Connell,et al.  Role of protein kinase C delta in curcumin-induced antioxidant response element-mediated gene expression in human monocytes. , 2006, Biochemical and biophysical research communications.

[5]  L. Howells,et al.  Involvement of Nrf2, p38, B-Raf, and Nuclear Factor-κB, but Not Phosphatidylinositol 3-Kinase, in Induction of Hemeoxygenase-1 by Dietary Polyphenols , 2006, Molecular Pharmacology.

[6]  J. Xu,et al.  Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1 , 2006, Oncogene.

[7]  D. Noonan,et al.  Molecular mechanisms of action of angiopreventive anti-oxidants on endothelial cells: microarray gene expression analyses. , 2005, Mutation research.

[8]  Y. Murakami,et al.  Induction of cytotoxicity and apoptosis and inhibition of cyclooxygenase-2 gene expression, by curcumin and its analog, alpha-diisoeugenol. , 2005, Anticancer research.

[9]  N. Sidell,et al.  Growth‐related oncogene produced in human breast cancer cells and regulated by Syk protein‐tyrosine kinase , 2005, International journal of cancer.

[10]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[11]  Y. Kluger,et al.  Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease. , 2005, Cancer research.

[12]  D. S. Chekmenev,et al.  P-Match: transcription factor binding site search by combining patterns and weight matrices , 2005, Nucleic Acids Res..

[13]  Allan R. Brasier,et al.  Identification of Direct Genomic Targets Downstream of the Nuclear Factor-κB Transcription Factor Mediating Tumor Necrosis Factor Signaling* , 2005, Journal of Biological Chemistry.

[14]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[15]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[16]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[17]  N. Chainani-Wu Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). , 2003, Journal of alternative and complementary medicine.

[18]  F. Balkwill Chemokine biology in cancer. , 2003, Seminars in immunology.

[19]  Sujay K. Singh,et al.  Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis , 2003 .

[20]  N. Tsuji,et al.  Overexpression of early growth response-1 as a metastasis-regulatory factor in gastric cancer. , 2002, Anticancer research.

[21]  P. Dhawan,et al.  Role of CXCL1 in tumorigenesis of melanoma , 2002, Journal of leukocyte biology.

[22]  Zuzana Dobbie,et al.  Processing of gene expression data generated by quantitative real-time RT-PCR. , 2002, BioTechniques.

[23]  L. Cornelius,et al.  The role of chemokines in melanoma tumor growth and metastasis. , 2002, The Journal of investigative dermatology.

[24]  Zhen-zhou Shen,et al.  Curcumin exerts multiple suppressive effects on human breast carcinoma cells , 2002, International journal of cancer.

[25]  F. Balkwill,et al.  Epithelial cancer cell migration: a role for chemokine receptors? , 2001, Cancer research.

[26]  Christine Brun,et al.  In silico prediction of protein-protein interactions in human macrophages , 2001, BMC Research Notes.

[27]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[28]  Wei Yang,et al.  MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression , 2000, Oncogene.

[29]  G. Dong,et al.  Growth Regulated Oncogene-α expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC Receptor-2 dependent mechanism , 2000, Oncogene.

[30]  Jen-kun Lin,et al.  Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. , 2000, Carcinogenesis.

[31]  D. Zhou,et al.  Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. , 1999, Anticancer research.

[32]  V. Steele,et al.  Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. , 1999, Cancer research.

[33]  P. Lin,et al.  The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids. , 1998, Environmental health perspectives.

[34]  Y. P. Lu,et al.  Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. , 1998, Carcinogenesis.

[35]  P. Limtrakul,et al.  Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. , 1997, Cancer letters.

[36]  B. Aggarwal,et al.  Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. , 1997, Anti-Cancer Drugs.

[37]  R. Rees,et al.  Chemokines induce migrational responses in human breast carcinoma cell lines , 1997, International journal of cancer.

[38]  Jen-kun Lin,et al.  Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. , 1996, Biochimica et biophysica acta.

[39]  B. Dewald,et al.  The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes. , 1993, The Journal of biological chemistry.

[40]  R. Fine,et al.  Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes , 1990, Journal of cellular biochemistry.

[41]  M. Olivé,et al.  Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization , 1978, In Vitro.

[42]  M. Olivé,et al.  Breast tumor cell lines from pleural effusions. , 1974, Journal of the National Cancer Institute.

[43]  J. Ross,et al.  Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. , 2007, International journal of molecular medicine.

[44]  N. Arber,et al.  Down-regulation of prostaglandin E2 by curcumin is correlated with inhibition of cell growth and induction of apoptosis in human colon carcinoma cell lines. , 2006, Journal of the Society for Integrative Oncology.

[45]  Robert Gentleman,et al.  An extensible application for assembling annotation for genomic data , 2003, Bioinform..

[46]  Sujay K. Singh,et al.  Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. , 2003, Blood.

[47]  Sujay K. Singh,et al.  Curcumin (Diferuloylmethane) Downregulates the Constitutive Activation of Nuclear Factor κB and IκBα Kinase in Human Multiple Myeloma Cells Leading to Suppression of Proliferation and Induction of Apoptosis , 2002 .

[48]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[49]  I. Fidler,et al.  Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. , 1991, Invasion & metastasis.